Detalles de la búsqueda
1.
Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence.
Future Oncol
; : 1-14, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861286
2.
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).
Health Qual Life Outcomes
; 19(1): 38, 2021 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516211
3.
Preoperative liver regeneration with CD133+ infusion in patients with colorectal liver metastases: proof-of concept trial.
HPB (Oxford)
; 26(4): 603-605, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310081
4.
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer.
Int J Cancer
; 143(8): 1954-1962, 2018 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29761480
5.
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Oncologist
; 23(11): 1271-e128, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120161
6.
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 16(7): 859-70, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26095784
7.
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.
BMC Cancer
; 15: 60, 2015 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886378
8.
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Lancet Oncol
; 14(1): 29-37, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23168366
9.
Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer.
Oncologist
; 18(8): 917-23, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23873719
10.
Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study.
BMC Cancer
; 13: 427, 2013 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24053191
11.
Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans.
JACS Au
; 3(3): 868-878, 2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006776
12.
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.
Clin Cancer Res
; 29(2): 379-388, 2023 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36074154
13.
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
Oncologist
; 17(3): 339-45, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22363067
14.
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
Oncologist
; 17(7): 947-55, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22643538
15.
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.
Oncologist
; 17(1): 15-25, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234633
16.
Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.
BMC Cancer
; 12: 260, 2012 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22712570
17.
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).
Clin Transl Oncol
; 24(4): 646-657, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303269
18.
Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets.
Cancers (Basel)
; 14(21)2022 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358609
19.
Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer.
Cancer Biomark
; 34(2): 201-210, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958006
20.
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Eur J Surg Oncol
; 48(5): 1123-1132, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34872775